| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Transfer | 79 | 2025 | 173 | 18.260 |
Why?
|
| RNA Processing, Post-Transcriptional | 30 | 2025 | 124 | 6.900 |
Why?
|
| Adenosine | 28 | 2024 | 278 | 6.420 |
Why?
|
| Protein Biosynthesis | 37 | 2025 | 399 | 5.620 |
Why?
|
| RNA | 36 | 2024 | 605 | 5.410 |
Why?
|
| RNA, Messenger | 33 | 2024 | 2090 | 5.110 |
Why?
|
| RNA, Catalytic | 36 | 2006 | 134 | 4.430 |
Why?
|
| Nucleic Acid Conformation | 52 | 2025 | 351 | 4.260 |
Why?
|
| Pseudouridine | 9 | 2024 | 22 | 4.030 |
Why?
|
| RNA, Long Noncoding | 14 | 2025 | 130 | 3.980 |
Why?
|
| Nucleoside Q | 7 | 2025 | 10 | 3.340 |
Why?
|
| High-Throughput Nucleotide Sequencing | 10 | 2024 | 540 | 3.090 |
Why?
|
| Bacillus subtilis | 30 | 2018 | 92 | 3.070 |
Why?
|
| Endoribonucleases | 25 | 2003 | 93 | 2.790 |
Why?
|
| RNA, Bacterial | 26 | 2024 | 112 | 2.750 |
Why?
|
| Transcriptome | 17 | 2025 | 769 | 2.720 |
Why?
|
| Transfer RNA Aminoacylation | 10 | 2020 | 20 | 2.350 |
Why?
|
| Stress, Physiological | 7 | 2025 | 252 | 2.210 |
Why?
|
| Escherichia coli | 17 | 2024 | 627 | 2.170 |
Why?
|
| Anticodon | 11 | 2022 | 19 | 2.020 |
Why?
|
| Amino Acids | 11 | 2023 | 262 | 1.980 |
Why?
|
| Methionine | 6 | 2017 | 68 | 1.970 |
Why?
|
| HEK293 Cells | 24 | 2025 | 706 | 1.950 |
Why?
|
| Sequence Analysis, RNA | 11 | 2024 | 259 | 1.860 |
Why?
|
| Escherichia coli Proteins | 10 | 2024 | 190 | 1.810 |
Why?
|
| Ribonuclease P | 36 | 2010 | 55 | 1.800 |
Why?
|
| RNA-Binding Proteins | 11 | 2020 | 305 | 1.790 |
Why?
|
| Base Sequence | 53 | 2023 | 2344 | 1.770 |
Why?
|
| RNA Stability | 10 | 2024 | 97 | 1.620 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2024 | 41 | 1.620 |
Why?
|
| Transcription, Genetic | 13 | 2025 | 1192 | 1.600 |
Why?
|
| RNA Precursors | 14 | 2019 | 73 | 1.590 |
Why?
|
| Codon | 14 | 2023 | 120 | 1.560 |
Why?
|
| MicroRNAs | 5 | 2025 | 591 | 1.540 |
Why?
|
| Humans | 144 | 2025 | 96105 | 1.460 |
Why?
|
| HeLa Cells | 21 | 2021 | 522 | 1.350 |
Why?
|
| Animals | 69 | 2025 | 28891 | 1.290 |
Why?
|
| Molecular Sequence Data | 40 | 2016 | 3040 | 1.260 |
Why?
|
| Microbiota | 5 | 2024 | 426 | 1.250 |
Why?
|
| Methylation | 14 | 2024 | 295 | 1.100 |
Why?
|
| Genome | 6 | 2025 | 407 | 1.090 |
Why?
|
| RNA, Transfer, Amino Acyl | 4 | 2017 | 10 | 1.090 |
Why?
|
| Alligators and Crocodiles | 2 | 2025 | 24 | 1.060 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 3157 | 1.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2016 | 701 | 1.040 |
Why?
|
| Models, Molecular | 24 | 2025 | 1375 | 1.030 |
Why?
|
| Saccharomyces cerevisiae | 13 | 2023 | 463 | 1.020 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2025 | 107 | 1.010 |
Why?
|
| Substrate Specificity | 25 | 2016 | 368 | 1.000 |
Why?
|
| Nanopores | 3 | 2024 | 8 | 0.990 |
Why?
|
| Genomics | 3 | 2025 | 857 | 0.990 |
Why?
|
| Mitochondria | 5 | 2025 | 622 | 0.980 |
Why?
|
| Cell Proliferation | 11 | 2025 | 1753 | 0.970 |
Why?
|
| Conservation of Natural Resources | 2 | 2025 | 98 | 0.960 |
Why?
|
| Mice | 36 | 2025 | 12537 | 0.950 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 58 | 0.940 |
Why?
|
| Neuroprotective Agents | 2 | 2023 | 102 | 0.940 |
Why?
|
| Adaptation, Biological | 2 | 2016 | 90 | 0.940 |
Why?
|
| Genetic Code | 6 | 2017 | 26 | 0.940 |
Why?
|
| RNA, Transfer, Phe | 12 | 2010 | 18 | 0.930 |
Why?
|
| Methyltransferases | 6 | 2020 | 213 | 0.920 |
Why?
|
| Breeding | 1 | 2025 | 42 | 0.900 |
Why?
|
| Computational Biology | 3 | 2024 | 586 | 0.890 |
Why?
|
| Cytosol | 1 | 2025 | 198 | 0.890 |
Why?
|
| Amino Acyl-tRNA Synthetases | 5 | 2020 | 15 | 0.880 |
Why?
|
| Cell Line, Tumor | 18 | 2025 | 2778 | 0.870 |
Why?
|
| Streptomyces | 1 | 2024 | 21 | 0.860 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2024 | 5 | 0.860 |
Why?
|
| Aflatoxin B1 | 1 | 2024 | 9 | 0.860 |
Why?
|
| Arachis | 1 | 2024 | 13 | 0.850 |
Why?
|
| Naphthoquinones | 2 | 2022 | 8 | 0.850 |
Why?
|
| Milk | 1 | 2023 | 56 | 0.790 |
Why?
|
| RNA, Ribosomal | 3 | 2019 | 72 | 0.790 |
Why?
|
| Neoplasms | 6 | 2024 | 3248 | 0.790 |
Why?
|
| Epigenesis, Genetic | 5 | 2025 | 555 | 0.780 |
Why?
|
| Mutation | 17 | 2023 | 4374 | 0.770 |
Why?
|
| Carcinoma, Hepatocellular | 7 | 2022 | 426 | 0.760 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2024 | 299 | 0.750 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 51 | 0.750 |
Why?
|
| Mutation, Missense | 1 | 2023 | 302 | 0.730 |
Why?
|
| RNA Folding | 2 | 2012 | 7 | 0.730 |
Why?
|
| 5-Methylcytosine | 3 | 2020 | 122 | 0.720 |
Why?
|
| Aptamers, Nucleotide | 3 | 2024 | 26 | 0.720 |
Why?
|
| Interferons | 2 | 2021 | 130 | 0.710 |
Why?
|
| Diamines | 1 | 2021 | 11 | 0.710 |
Why?
|
| AlkB Enzymes | 2 | 2021 | 4 | 0.700 |
Why?
|
| Parkinson Disease | 1 | 2023 | 178 | 0.680 |
Why?
|
| Liver Neoplasms | 8 | 2022 | 793 | 0.680 |
Why?
|
| Directed Molecular Evolution | 1 | 2021 | 21 | 0.680 |
Why?
|
| Ribosomes | 6 | 2025 | 122 | 0.680 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2061 | 0.670 |
Why?
|
| Oxidative Stress | 5 | 2025 | 473 | 0.670 |
Why?
|
| Proteins | 6 | 2017 | 816 | 0.670 |
Why?
|
| Mixed Function Oxygenases | 1 | 2021 | 69 | 0.670 |
Why?
|
| Histone Deacetylases | 1 | 2021 | 86 | 0.660 |
Why?
|
| Leukemia Virus, Murine | 1 | 2020 | 18 | 0.650 |
Why?
|
| Lung Neoplasms | 8 | 2023 | 2463 | 0.650 |
Why?
|
| Gels | 1 | 2020 | 53 | 0.650 |
Why?
|
| Nucleic Acid Hybridization | 6 | 2010 | 242 | 0.640 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2020 | 68 | 0.630 |
Why?
|
| Lymphatic Metastasis | 3 | 2020 | 514 | 0.630 |
Why?
|
| Protein Binding | 15 | 2021 | 1560 | 0.630 |
Why?
|
| Cochlear Implantation | 5 | 2023 | 34 | 0.620 |
Why?
|
| Stomach Neoplasms | 5 | 2025 | 310 | 0.600 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 2 | 2016 | 2 | 0.590 |
Why?
|
| RNA, Transfer, Met | 2 | 2015 | 6 | 0.560 |
Why?
|
| Magnesium | 13 | 2008 | 178 | 0.560 |
Why?
|
| Sepsis | 1 | 2022 | 391 | 0.560 |
Why?
|
| Guanosine | 2 | 2021 | 31 | 0.560 |
Why?
|
| Kinetics | 19 | 2014 | 1562 | 0.550 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 854 | 0.540 |
Why?
|
| Peptide Chain Initiation, Translational | 4 | 2016 | 17 | 0.540 |
Why?
|
| Binding Sites | 13 | 2021 | 1167 | 0.540 |
Why?
|
| Fluorescent Dyes | 3 | 2016 | 262 | 0.520 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 611 | 0.520 |
Why?
|
| Microarray Analysis | 1 | 2016 | 98 | 0.500 |
Why?
|
| Gene Library | 2 | 2015 | 134 | 0.490 |
Why?
|
| Cochlear Implants | 3 | 2023 | 37 | 0.490 |
Why?
|
| Methionine-tRNA Ligase | 5 | 2017 | 8 | 0.490 |
Why?
|
| Protein Folding | 6 | 2007 | 295 | 0.490 |
Why?
|
| Chromatography, Thin Layer | 1 | 2016 | 33 | 0.480 |
Why?
|
| Aeropyrum | 1 | 2015 | 2 | 0.480 |
Why?
|
| Cell Line | 9 | 2024 | 2537 | 0.480 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 24 | 0.480 |
Why?
|
| Archaeal Proteins | 1 | 2015 | 26 | 0.470 |
Why?
|
| DNA, Complementary | 5 | 2021 | 394 | 0.470 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2015 | 4 | 0.460 |
Why?
|
| Prions | 2 | 2005 | 52 | 0.450 |
Why?
|
| Gene Expression Profiling | 7 | 2024 | 1535 | 0.450 |
Why?
|
| Water Supply | 1 | 2015 | 66 | 0.450 |
Why?
|
| Bacteria | 4 | 2024 | 517 | 0.450 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2012 | 220 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 3489 | 0.440 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 590 | 0.440 |
Why?
|
| Apoptosis | 7 | 2021 | 1756 | 0.440 |
Why?
|
| Temperature | 2 | 2015 | 426 | 0.430 |
Why?
|
| Climate Change | 1 | 2015 | 62 | 0.430 |
Why?
|
| Acylation | 4 | 2018 | 68 | 0.420 |
Why?
|
| Structure-Activity Relationship | 7 | 2021 | 436 | 0.420 |
Why?
|
| RNA, Untranslated | 3 | 2018 | 69 | 0.420 |
Why?
|
| Reverse Transcription | 4 | 2019 | 14 | 0.420 |
Why?
|
| Aminoacylation | 4 | 2023 | 6 | 0.420 |
Why?
|
| Discriminant Analysis | 2 | 2024 | 66 | 0.410 |
Why?
|
| Least-Squares Analysis | 2 | 2024 | 50 | 0.410 |
Why?
|
| Lymphoma, Mantle-Cell | 2 | 2025 | 43 | 0.410 |
Why?
|
| Food Contamination | 2 | 2024 | 35 | 0.410 |
Why?
|
| Cocaine-Related Disorders | 2 | 2024 | 41 | 0.400 |
Why?
|
| Protein Conformation | 6 | 2020 | 935 | 0.400 |
Why?
|
| China | 5 | 2025 | 264 | 0.400 |
Why?
|
| Cocaine | 2 | 2024 | 81 | 0.400 |
Why?
|
| 5' Untranslated Regions | 2 | 2016 | 54 | 0.390 |
Why?
|
| Staining and Labeling | 1 | 2013 | 172 | 0.390 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2015 | 301 | 0.390 |
Why?
|
| RNA, Transfer, Ser | 1 | 2012 | 2 | 0.390 |
Why?
|
| Glycosylation | 3 | 2021 | 137 | 0.380 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2025 | 106 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2025 | 1346 | 0.370 |
Why?
|
| Riboswitch | 1 | 2012 | 6 | 0.370 |
Why?
|
| Aspartate-tRNA Ligase | 1 | 2011 | 1 | 0.360 |
Why?
|
| RNA, Transfer, Asp | 1 | 2011 | 1 | 0.360 |
Why?
|
| Codon, Nonsense | 1 | 2012 | 47 | 0.360 |
Why?
|
| Alu Elements | 1 | 2011 | 16 | 0.350 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2012 | 57 | 0.350 |
Why?
|
| Lipopolysaccharides | 2 | 2023 | 305 | 0.350 |
Why?
|
| DNA-Directed RNA Polymerases | 3 | 2025 | 106 | 0.350 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 100 | 0.350 |
Why?
|
| Thermodynamics | 13 | 2008 | 329 | 0.340 |
Why?
|
| Phylogeny | 10 | 2017 | 1275 | 0.340 |
Why?
|
| Circadian Clocks | 2 | 2022 | 66 | 0.340 |
Why?
|
| Catalysis | 11 | 2010 | 216 | 0.340 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 170 | 0.330 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 340 | 0.330 |
Why?
|
| Charcot-Marie-Tooth Disease | 2 | 2021 | 6 | 0.330 |
Why?
|
| Cecum | 3 | 2024 | 78 | 0.330 |
Why?
|
| Genetic Variation | 4 | 2023 | 1423 | 0.320 |
Why?
|
| Female | 31 | 2025 | 50028 | 0.320 |
Why?
|
| HIV-1 | 4 | 2020 | 182 | 0.310 |
Why?
|
| Biomarkers, Tumor | 3 | 2025 | 1670 | 0.310 |
Why?
|
| DNA Methylation | 4 | 2022 | 703 | 0.310 |
Why?
|
| Oligonucleotides | 2 | 2009 | 92 | 0.310 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2025 | 528 | 0.310 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 555 | 0.310 |
Why?
|
| Male | 36 | 2025 | 45863 | 0.310 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 120 | 0.310 |
Why?
|
| Machine Learning | 2 | 2024 | 348 | 0.300 |
Why?
|
| Cell Movement | 3 | 2025 | 816 | 0.300 |
Why?
|
| Cluster Analysis | 2 | 2023 | 393 | 0.300 |
Why?
|
| Proteasome Inhibitors | 1 | 2009 | 54 | 0.300 |
Why?
|
| Boronic Acids | 1 | 2009 | 55 | 0.300 |
Why?
|
| Catalytic Domain | 8 | 2015 | 165 | 0.300 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 72 | 0.300 |
Why?
|
| Water Pollutants, Chemical | 2 | 2020 | 140 | 0.300 |
Why?
|
| Alternative Splicing | 4 | 2019 | 220 | 0.290 |
Why?
|
| PrPSc Proteins | 2 | 2005 | 21 | 0.290 |
Why?
|
| Sequence Alignment | 3 | 2018 | 360 | 0.290 |
Why?
|
| Pyrazines | 1 | 2009 | 94 | 0.290 |
Why?
|
| Genome, Human | 1 | 2013 | 824 | 0.290 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2023 | 644 | 0.290 |
Why?
|
| Speech Perception | 2 | 2022 | 74 | 0.290 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2019 | 21 | 0.280 |
Why?
|
| Virus Replication | 3 | 2020 | 326 | 0.280 |
Why?
|
| Retrospective Studies | 15 | 2024 | 10287 | 0.280 |
Why?
|
| Catheter Ablation | 3 | 2019 | 266 | 0.280 |
Why?
|
| Drug-Seeking Behavior | 2 | 2025 | 12 | 0.280 |
Why?
|
| RNA, Fungal | 4 | 2007 | 43 | 0.280 |
Why?
|
| Genome, Fungal | 2 | 2023 | 36 | 0.280 |
Why?
|
| Urea | 7 | 2001 | 60 | 0.280 |
Why?
|
| DNA Damage | 2 | 2021 | 392 | 0.280 |
Why?
|
| Brain | 6 | 2024 | 2482 | 0.270 |
Why?
|
| Leucovorin | 2 | 2019 | 227 | 0.270 |
Why?
|
| Prognosis | 7 | 2025 | 4028 | 0.270 |
Why?
|
| Polyribosomes | 3 | 2024 | 21 | 0.270 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 2880 | 0.270 |
Why?
|
| Ribonuclease, Pancreatic | 4 | 2018 | 24 | 0.270 |
Why?
|
| Amino Acid Sequence | 5 | 2020 | 2090 | 0.270 |
Why?
|
| Organ Specificity | 2 | 2016 | 286 | 0.270 |
Why?
|
| Evolution, Molecular | 7 | 2023 | 891 | 0.260 |
Why?
|
| Immunity, Innate | 2 | 2012 | 464 | 0.260 |
Why?
|
| Arsenites | 2 | 2025 | 7 | 0.260 |
Why?
|
| Mice, Nude | 5 | 2025 | 830 | 0.260 |
Why?
|
| Algorithms | 1 | 2015 | 2015 | 0.260 |
Why?
|
| Models, Chemical | 7 | 2007 | 187 | 0.250 |
Why?
|
| Models, Biological | 3 | 2011 | 1809 | 0.250 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2023 | 10 | 0.250 |
Why?
|
| RNA Cleavage | 2 | 2018 | 7 | 0.250 |
Why?
|
| Genome, Mitochondrial | 3 | 2017 | 32 | 0.250 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 1172 | 0.250 |
Why?
|
| DNA | 4 | 2022 | 1333 | 0.250 |
Why?
|
| Dopaminergic Neurons | 2 | 2023 | 30 | 0.250 |
Why?
|
| Mammals | 3 | 2022 | 261 | 0.240 |
Why?
|
| RNA, Viral | 3 | 2020 | 311 | 0.240 |
Why?
|
| Genetic Techniques | 1 | 2006 | 75 | 0.240 |
Why?
|
| Ribonucleoproteins | 3 | 2014 | 37 | 0.240 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 517 | 0.240 |
Why?
|
| Cell Differentiation | 3 | 2024 | 1667 | 0.240 |
Why?
|
| Ecosystem | 2 | 2022 | 394 | 0.240 |
Why?
|
| Nucleotide Motifs | 3 | 2015 | 49 | 0.240 |
Why?
|
| Holoenzymes | 6 | 2010 | 10 | 0.240 |
Why?
|
| Water | 2 | 2024 | 307 | 0.230 |
Why?
|
| Transcription Factors | 4 | 2021 | 1730 | 0.230 |
Why?
|
| Deoxycholic Acid | 1 | 2025 | 13 | 0.230 |
Why?
|
| Extracellular Traps | 1 | 2025 | 16 | 0.230 |
Why?
|
| Cell Nucleus | 4 | 2013 | 623 | 0.230 |
Why?
|
| Thrombin | 1 | 2025 | 61 | 0.230 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2025 | 41 | 0.230 |
Why?
|
| STAT1 Transcription Factor | 1 | 2025 | 58 | 0.230 |
Why?
|
| Heroin Dependence | 1 | 2025 | 16 | 0.230 |
Why?
|
| Endangered Species | 1 | 2025 | 26 | 0.230 |
Why?
|
| Inbreeding | 1 | 2025 | 48 | 0.230 |
Why?
|
| Heroin | 1 | 2025 | 14 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 847 | 0.230 |
Why?
|
| Aminopyridines | 1 | 2025 | 49 | 0.220 |
Why?
|
| Multiple Myeloma | 1 | 2009 | 354 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 725 | 0.220 |
Why?
|
| RNA, Small Nucleolar | 1 | 2024 | 8 | 0.220 |
Why?
|
| Oils | 1 | 2024 | 7 | 0.220 |
Why?
|
| DNA, Single-Stranded | 1 | 2025 | 97 | 0.220 |
Why?
|
| Lymphoma, T-Cell | 1 | 2025 | 61 | 0.220 |
Why?
|
| Paternal Exposure | 1 | 2024 | 4 | 0.220 |
Why?
|
| Molecular Chaperones | 1 | 2025 | 127 | 0.220 |
Why?
|
| Prion Diseases | 1 | 2005 | 31 | 0.220 |
Why?
|
| Gallic Acid | 1 | 2024 | 7 | 0.220 |
Why?
|
| Models, Genetic | 5 | 2017 | 984 | 0.220 |
Why?
|
| Serratia | 1 | 2024 | 3 | 0.220 |
Why?
|
| Soil Pollutants | 1 | 2024 | 8 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 380 | 0.220 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2024 | 49 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2021 | 396 | 0.220 |
Why?
|
| Narcotics | 1 | 2025 | 72 | 0.220 |
Why?
|
| Biodegradation, Environmental | 1 | 2024 | 18 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 2534 | 0.220 |
Why?
|
| Soil Microbiology | 1 | 2024 | 28 | 0.210 |
Why?
|
| Metals, Heavy | 1 | 2024 | 17 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2019 | 2777 | 0.210 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 2 | 2015 | 19 | 0.210 |
Why?
|
| Benzamides | 1 | 2025 | 248 | 0.210 |
Why?
|
| Diet, High-Fat | 1 | 2025 | 134 | 0.210 |
Why?
|
| Glutathione | 1 | 2024 | 107 | 0.210 |
Why?
|
| Drosophila | 2 | 2021 | 539 | 0.210 |
Why?
|
| Nucleus Accumbens | 1 | 2025 | 113 | 0.210 |
Why?
|
| Peptide Elongation Factors | 2 | 2005 | 28 | 0.210 |
Why?
|
| Cloning, Molecular | 3 | 2020 | 648 | 0.210 |
Why?
|
| Copper | 1 | 2024 | 81 | 0.210 |
Why?
|
| Calibration | 1 | 2024 | 108 | 0.210 |
Why?
|
| Hydroxyl Radical | 6 | 2002 | 36 | 0.210 |
Why?
|
| Albuminuria | 1 | 2024 | 51 | 0.210 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 2023 | 36 | 0.210 |
Why?
|
| rho-Associated Kinases | 1 | 2025 | 162 | 0.210 |
Why?
|
| Evodia | 1 | 2023 | 1 | 0.210 |
Why?
|
| Margins of Excision | 1 | 2024 | 45 | 0.210 |
Why?
|
| Frozen Sections | 1 | 2024 | 50 | 0.210 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 77 | 0.210 |
Why?
|
| Neutrophils | 1 | 2025 | 332 | 0.210 |
Why?
|
| Drug Design | 2 | 2021 | 133 | 0.200 |
Why?
|
| Plants, Medicinal | 1 | 2023 | 40 | 0.200 |
Why?
|
| Hearing Loss | 1 | 2024 | 65 | 0.200 |
Why?
|
| Pancreatic Diseases | 1 | 2023 | 59 | 0.200 |
Why?
|
| Interleukin-18 | 1 | 2023 | 29 | 0.200 |
Why?
|
| Bacterial Proteins | 5 | 2013 | 922 | 0.200 |
Why?
|
| Base Pairing | 3 | 2016 | 56 | 0.200 |
Why?
|
| Circular Dichroism | 9 | 2010 | 118 | 0.200 |
Why?
|
| Testosterone | 2 | 2022 | 277 | 0.200 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 28 | 0.200 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2023 | 58 | 0.200 |
Why?
|
| Nutrition Surveys | 1 | 2024 | 125 | 0.200 |
Why?
|
| Inflammasomes | 1 | 2023 | 31 | 0.200 |
Why?
|
| Dysbiosis | 1 | 2024 | 91 | 0.200 |
Why?
|
| Inverted Repeat Sequences | 2 | 2013 | 10 | 0.200 |
Why?
|
| Mastectomy, Segmental | 1 | 2024 | 108 | 0.190 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2015 | 167 | 0.190 |
Why?
|
| Periodic Acid | 1 | 2022 | 4 | 0.190 |
Why?
|
| Plasmodium yoelii | 1 | 2022 | 5 | 0.190 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2022 | 7 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 93 | 0.190 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2022 | 9 | 0.190 |
Why?
|
| Sulfur | 1 | 2022 | 30 | 0.190 |
Why?
|
| Malaria | 1 | 2022 | 26 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 2642 | 0.190 |
Why?
|
| Hepatitis B | 1 | 2023 | 82 | 0.190 |
Why?
|
| Leydig Cells | 1 | 2022 | 11 | 0.190 |
Why?
|
| Microglia | 1 | 2023 | 124 | 0.190 |
Why?
|
| Powders | 1 | 2023 | 83 | 0.190 |
Why?
|
| Semaphorins | 1 | 2022 | 18 | 0.190 |
Why?
|
| Lung | 2 | 2020 | 1384 | 0.190 |
Why?
|
| Ecology | 1 | 2023 | 82 | 0.190 |
Why?
|
| Biocatalysis | 3 | 2024 | 56 | 0.190 |
Why?
|
| Thrombosis | 1 | 2025 | 326 | 0.190 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2022 | 13 | 0.190 |
Why?
|
| beta-Thalassemia | 1 | 2022 | 6 | 0.190 |
Why?
|
| Environmental Monitoring | 1 | 2022 | 89 | 0.190 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 72 | 0.180 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 750 | 0.180 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 62 | 0.180 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1765 | 0.180 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 154 | 0.180 |
Why?
|
| Codon, Terminator | 2 | 2013 | 22 | 0.180 |
Why?
|
| Hydrolysis | 5 | 2001 | 146 | 0.180 |
Why?
|
| Regulon | 1 | 2021 | 17 | 0.180 |
Why?
|
| Ossicular Prosthesis | 1 | 2021 | 6 | 0.180 |
Why?
|
| Burkitt Lymphoma | 1 | 2022 | 34 | 0.180 |
Why?
|
| Receptor, ErbB-2 | 1 | 2024 | 280 | 0.180 |
Why?
|
| Ossicular Replacement | 1 | 2021 | 8 | 0.180 |
Why?
|
| Rats | 5 | 2025 | 4155 | 0.180 |
Why?
|
| Genetics, Population | 2 | 2023 | 437 | 0.180 |
Why?
|
| Alanine-tRNA Ligase | 1 | 2021 | 1 | 0.170 |
Why?
|
| Neuropilin-1 | 1 | 2021 | 14 | 0.170 |
Why?
|
| AlkB Homolog 1, Histone H2a Dioxygenase | 2 | 2022 | 4 | 0.170 |
Why?
|
| Mutagenesis | 3 | 2013 | 202 | 0.170 |
Why?
|
| Protein Transport | 2 | 2015 | 439 | 0.170 |
Why?
|
| Thyroid Hormones | 1 | 2024 | 352 | 0.170 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 84 | 0.170 |
Why?
|
| Fluorometry | 1 | 2021 | 31 | 0.170 |
Why?
|
| Lead | 1 | 2001 | 32 | 0.170 |
Why?
|
| Recidivism | 1 | 2021 | 3 | 0.170 |
Why?
|
| Mastoidectomy | 1 | 2021 | 3 | 0.170 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2021 | 69 | 0.170 |
Why?
|
| Carcinogenesis | 2 | 2022 | 235 | 0.170 |
Why?
|
| Gastroscopy | 1 | 2021 | 25 | 0.170 |
Why?
|
| Magnets | 1 | 2021 | 12 | 0.170 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2021 | 8 | 0.170 |
Why?
|
| Cholesteatoma | 1 | 2021 | 7 | 0.170 |
Why?
|
| Biochemistry | 1 | 2001 | 31 | 0.170 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2020 | 11 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2025 | 589 | 0.170 |
Why?
|
| Conservative Treatment | 1 | 2021 | 27 | 0.170 |
Why?
|
| Cisplatin | 2 | 2020 | 611 | 0.170 |
Why?
|
| RNA-Directed DNA Polymerase | 2 | 2018 | 16 | 0.170 |
Why?
|
| Dendritic Cells | 1 | 2025 | 541 | 0.170 |
Why?
|
| RNA, Transfer, Lys | 2 | 2018 | 3 | 0.170 |
Why?
|
| Polyphenols | 1 | 2020 | 13 | 0.170 |
Why?
|
| Water Purification | 1 | 2020 | 4 | 0.170 |
Why?
|
| Rodentia | 1 | 2021 | 47 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 358 | 0.170 |
Why?
|
| THP-1 Cells | 1 | 2020 | 9 | 0.170 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2020 | 17 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 4 | 2011 | 750 | 0.160 |
Why?
|
| Emergency Treatment | 1 | 2021 | 48 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2009 | 282 | 0.160 |
Why?
|
| Alanine | 2 | 2020 | 85 | 0.160 |
Why?
|
| A549 Cells | 1 | 2020 | 51 | 0.160 |
Why?
|
| Middle Aged | 15 | 2025 | 28368 | 0.160 |
Why?
|
| Software | 1 | 2024 | 698 | 0.160 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 129 | 0.160 |
Why?
|
| tRNA Methyltransferases | 3 | 2024 | 14 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 171 | 0.160 |
Why?
|
| Abdomen | 1 | 2021 | 127 | 0.160 |
Why?
|
| Fluorouracil | 2 | 2019 | 555 | 0.160 |
Why?
|
| Bacteroidetes | 2 | 2018 | 40 | 0.160 |
Why?
|
| Suppuration | 1 | 2020 | 8 | 0.160 |
Why?
|
| Hydro-Lyases | 1 | 2020 | 7 | 0.160 |
Why?
|
| HIV Protease | 1 | 2020 | 10 | 0.160 |
Why?
|
| NIH 3T3 Cells | 1 | 2020 | 112 | 0.160 |
Why?
|
| Self Administration | 3 | 2025 | 76 | 0.160 |
Why?
|
| Foreign Bodies | 1 | 2021 | 66 | 0.160 |
Why?
|
| Dental Pulp | 1 | 2020 | 5 | 0.160 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 139 | 0.160 |
Why?
|
| NF-kappa B | 1 | 2023 | 469 | 0.160 |
Why?
|
| Genome, Viral | 1 | 2020 | 80 | 0.160 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 270 | 0.160 |
Why?
|
| Sp1 Transcription Factor | 1 | 2020 | 24 | 0.160 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 89 | 0.160 |
Why?
|
| Phosphorylation | 7 | 2013 | 1157 | 0.160 |
Why?
|
| Retroviridae | 1 | 2020 | 76 | 0.160 |
Why?
|
| Bromates | 1 | 2019 | 1 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2022 | 346 | 0.160 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 56 | 0.160 |
Why?
|
| Polybrominated Biphenyls | 1 | 2019 | 5 | 0.160 |
Why?
|
| RNA Editing | 1 | 2020 | 48 | 0.160 |
Why?
|
| Histidine-tRNA Ligase | 1 | 2019 | 1 | 0.160 |
Why?
|
| Sodium | 1 | 2001 | 340 | 0.160 |
Why?
|
| Treatment Outcome | 11 | 2023 | 9175 | 0.150 |
Why?
|
| Osteoblasts | 1 | 2020 | 98 | 0.150 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 246 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-2 | 4 | 2013 | 18 | 0.150 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 144 | 0.150 |
Why?
|
| Phenanthrolines | 1 | 2019 | 8 | 0.150 |
Why?
|
| Ruthenium | 1 | 2019 | 5 | 0.150 |
Why?
|
| RNA, Small Nuclear | 1 | 2019 | 36 | 0.150 |
Why?
|
| Blotting, Northern | 2 | 2017 | 258 | 0.150 |
Why?
|
| Gene Expression | 2 | 2021 | 1320 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 897 | 0.150 |
Why?
|
| Ceftriaxone | 1 | 2019 | 9 | 0.150 |
Why?
|
| Neuroblastoma | 1 | 2022 | 400 | 0.150 |
Why?
|
| Macrophages | 1 | 2022 | 623 | 0.150 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2018 | 12 | 0.150 |
Why?
|
| Anemia, Hemolytic | 1 | 2019 | 19 | 0.150 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 62 | 0.150 |
Why?
|
| Interleukin-6 | 1 | 2020 | 281 | 0.150 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 308 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2021 | 386 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2025 | 1471 | 0.140 |
Why?
|
| CME-Carbodiimide | 1 | 2018 | 1 | 0.140 |
Why?
|
| Base Pair Mismatch | 2 | 2013 | 27 | 0.140 |
Why?
|
| Base Composition | 4 | 2022 | 38 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 580 | 0.140 |
Why?
|
| Hepatic Artery | 1 | 2019 | 84 | 0.140 |
Why?
|
| Thermotoga maritima | 2 | 2010 | 16 | 0.140 |
Why?
|
| Amination | 1 | 2018 | 5 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2022 | 91 | 0.140 |
Why?
|
| Child | 8 | 2024 | 7625 | 0.140 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2019 | 85 | 0.140 |
Why?
|
| Deafness | 2 | 2015 | 48 | 0.140 |
Why?
|
| Ribonucleases | 1 | 2018 | 97 | 0.140 |
Why?
|
| Meckel Diverticulum | 1 | 2017 | 6 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 394 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2022 | 441 | 0.140 |
Why?
|
| Organometallic Compounds | 1 | 2019 | 148 | 0.140 |
Why?
|
| RNA Probes | 2 | 2016 | 16 | 0.140 |
Why?
|
| Anseriformes | 1 | 2017 | 1 | 0.140 |
Why?
|
| Pericardium | 1 | 2018 | 73 | 0.140 |
Why?
|
| Crystallography, X-Ray | 7 | 2021 | 527 | 0.130 |
Why?
|
| Argonaute Proteins | 1 | 2017 | 12 | 0.130 |
Why?
|
| Open Reading Frames | 2 | 2014 | 124 | 0.130 |
Why?
|
| Nucleotides | 3 | 2017 | 99 | 0.130 |
Why?
|
| Demethylation | 1 | 2017 | 12 | 0.130 |
Why?
|
| Cryoelectron Microscopy | 2 | 2025 | 115 | 0.130 |
Why?
|
| Proteomics | 2 | 2023 | 268 | 0.130 |
Why?
|
| Oxidation-Reduction | 4 | 2020 | 411 | 0.130 |
Why?
|
| Firmicutes | 1 | 2017 | 14 | 0.130 |
Why?
|
| Disease | 1 | 2018 | 93 | 0.130 |
Why?
|
| Pyridines | 1 | 2019 | 319 | 0.130 |
Why?
|
| Printing | 1 | 2016 | 4 | 0.130 |
Why?
|
| Anaerobiosis | 1 | 2016 | 22 | 0.130 |
Why?
|
| Sulfur Radioisotopes | 1 | 2016 | 21 | 0.130 |
Why?
|
| Carbon Radioisotopes | 1 | 2016 | 35 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2494 | 0.130 |
Why?
|
| Tritium | 1 | 2016 | 134 | 0.130 |
Why?
|
| Aged | 12 | 2025 | 20968 | 0.130 |
Why?
|
| Codon, Initiator | 2 | 2016 | 18 | 0.120 |
Why?
|
| Glioma | 1 | 2019 | 321 | 0.120 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2016 | 15 | 0.120 |
Why?
|
| RNA Transport | 2 | 2013 | 11 | 0.120 |
Why?
|
| Viral Proteins | 2 | 2012 | 289 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2020 | 683 | 0.120 |
Why?
|
| Peroxides | 3 | 2020 | 13 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 943 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2024 | 509 | 0.120 |
Why?
|
| RNA, Transfer, Glu | 1 | 2016 | 3 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 2474 | 0.120 |
Why?
|
| Citrate (si)-Synthase | 1 | 2015 | 3 | 0.120 |
Why?
|
| Genes, Mitochondrial | 1 | 2015 | 11 | 0.120 |
Why?
|
| Radioisotopes | 1 | 2016 | 43 | 0.120 |
Why?
|
| Amphibians | 1 | 2015 | 20 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2021 | 766 | 0.120 |
Why?
|
| Thermus thermophilus | 2 | 2006 | 10 | 0.120 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2013 | 49 | 0.120 |
Why?
|
| Organophosphorus Compounds | 2 | 2011 | 53 | 0.120 |
Why?
|
| Speech Intelligibility | 1 | 2015 | 10 | 0.120 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2007 | 86 | 0.110 |
Why?
|
| Tibet | 1 | 2015 | 22 | 0.110 |
Why?
|
| Epigenomics | 1 | 2016 | 109 | 0.110 |
Why?
|
| Metals | 3 | 2023 | 102 | 0.110 |
Why?
|
| Quality of Life | 1 | 2024 | 1816 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2025 | 3581 | 0.110 |
Why?
|
| Adult | 13 | 2025 | 28721 | 0.110 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 1034 | 0.110 |
Why?
|
| Lysine | 1 | 2016 | 190 | 0.110 |
Why?
|
| Infant | 5 | 2024 | 3363 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 3 | 2024 | 1124 | 0.110 |
Why?
|
| Biodiversity | 1 | 2017 | 238 | 0.110 |
Why?
|
| Heat-Shock Response | 1 | 2015 | 54 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 139 | 0.110 |
Why?
|
| Cross-Linking Reagents | 1 | 2015 | 92 | 0.110 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 336 | 0.110 |
Why?
|
| Child, Preschool | 5 | 2024 | 3974 | 0.110 |
Why?
|
| Micelles | 1 | 2014 | 53 | 0.110 |
Why?
|
| Apoptosomes | 1 | 2014 | 2 | 0.110 |
Why?
|
| Cytochromes c | 1 | 2014 | 28 | 0.110 |
Why?
|
| Adenine | 1 | 2014 | 92 | 0.110 |
Why?
|
| Genome, Insect | 1 | 2014 | 78 | 0.110 |
Why?
|
| Ultraviolet Rays | 2 | 2014 | 198 | 0.110 |
Why?
|
| Dimerization | 2 | 2005 | 150 | 0.100 |
Why?
|
| Video-Assisted Surgery | 1 | 2014 | 7 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 114 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2014 | 88 | 0.100 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 810 | 0.100 |
Why?
|
| Plasmids | 2 | 2012 | 291 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2012 | 217 | 0.100 |
Why?
|
| Radiation Tolerance | 1 | 2014 | 176 | 0.100 |
Why?
|
| Consensus Sequence | 1 | 2013 | 67 | 0.100 |
Why?
|
| Testis | 2 | 2021 | 153 | 0.100 |
Why?
|
| Frameshifting, Ribosomal | 1 | 2013 | 5 | 0.100 |
Why?
|
| Neck Dissection | 1 | 2014 | 68 | 0.100 |
Why?
|
| Bothrops | 1 | 2013 | 1 | 0.100 |
Why?
|
| Spleen | 2 | 2022 | 439 | 0.100 |
Why?
|
| Conserved Sequence | 5 | 2017 | 215 | 0.100 |
Why?
|
| Doxorubicin | 1 | 2014 | 304 | 0.100 |
Why?
|
| Cadaver | 1 | 2014 | 204 | 0.100 |
Why?
|
| Digestive System Neoplasms | 2 | 2004 | 22 | 0.100 |
Why?
|
| Lymph Nodes | 2 | 2007 | 565 | 0.100 |
Why?
|
| Biological Evolution | 2 | 2012 | 1030 | 0.100 |
Why?
|
| Databases, Protein | 1 | 2013 | 52 | 0.100 |
Why?
|
| Cochlear Nerve | 1 | 2013 | 9 | 0.100 |
Why?
|
| Species Specificity | 4 | 2021 | 707 | 0.100 |
Why?
|
| Tryptophan | 2 | 2010 | 105 | 0.100 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 58 | 0.100 |
Why?
|
| Vaccinia virus | 1 | 2012 | 20 | 0.100 |
Why?
|
| Thyroidectomy | 1 | 2014 | 173 | 0.100 |
Why?
|
| Stem Cell Factor | 1 | 2012 | 19 | 0.100 |
Why?
|
| Transcriptional Elongation Factors | 2 | 2005 | 24 | 0.100 |
Why?
|
| Yeasts | 3 | 2007 | 51 | 0.100 |
Why?
|
| Ferrous Compounds | 3 | 1998 | 18 | 0.100 |
Why?
|
| Fungal Proteins | 1 | 2013 | 147 | 0.100 |
Why?
|
| Erythroid Precursor Cells | 1 | 2012 | 33 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2013 | 154 | 0.100 |
Why?
|
| Edetic Acid | 3 | 1998 | 42 | 0.100 |
Why?
|
| RNA, Transfer, Leu | 1 | 2012 | 11 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2939 | 0.090 |
Why?
|
| Drug Synergism | 2 | 2025 | 317 | 0.090 |
Why?
|
| Nanotechnology | 1 | 2013 | 73 | 0.090 |
Why?
|
| Erythropoietin | 1 | 2012 | 91 | 0.090 |
Why?
|
| Neoplasm Metastasis | 3 | 2025 | 1094 | 0.090 |
Why?
|
| Forecasting | 1 | 2013 | 317 | 0.090 |
Why?
|
| Cobamides | 1 | 2012 | 2 | 0.090 |
Why?
|
| RNA Polymerase I | 1 | 2012 | 7 | 0.090 |
Why?
|
| Gastrectomy | 1 | 2012 | 70 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 90 | 0.090 |
Why?
|
| Influenza A virus | 1 | 2012 | 177 | 0.090 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2012 | 175 | 0.090 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 180 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2025 | 1267 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 256 | 0.090 |
Why?
|
| Hydrogen Peroxide | 2 | 2022 | 165 | 0.090 |
Why?
|
| Dopamine | 2 | 2024 | 283 | 0.090 |
Why?
|
| Iron | 2 | 2024 | 179 | 0.090 |
Why?
|
| Protein Subunits | 2 | 2002 | 126 | 0.090 |
Why?
|
| Diethyl Pyrocarbonate | 2 | 2001 | 5 | 0.090 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2004 | 134 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2009 | 281 | 0.090 |
Why?
|
| Tympanoplasty | 2 | 2021 | 13 | 0.090 |
Why?
|
| Siloxanes | 1 | 2011 | 5 | 0.090 |
Why?
|
| Styrenes | 1 | 2011 | 7 | 0.090 |
Why?
|
| RNA Splicing | 1 | 2013 | 159 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 314 | 0.090 |
Why?
|
| Geobacillus stearothermophilus | 3 | 2008 | 10 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2012 | 209 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2025 | 526 | 0.080 |
Why?
|
| DNA Repair Enzymes | 1 | 2011 | 61 | 0.080 |
Why?
|
| Antigen Presentation | 1 | 2012 | 229 | 0.080 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2004 | 126 | 0.080 |
Why?
|
| Transfection | 1 | 2012 | 908 | 0.080 |
Why?
|
| Nucleic Acid Heteroduplexes | 2 | 2001 | 11 | 0.080 |
Why?
|
| Uridine | 1 | 2010 | 59 | 0.080 |
Why?
|
| Primary Cell Culture | 2 | 2021 | 83 | 0.080 |
Why?
|
| Hep G2 Cells | 2 | 2021 | 54 | 0.080 |
Why?
|
| Young Adult | 5 | 2024 | 7025 | 0.080 |
Why?
|
| Cytosine | 1 | 2011 | 135 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 4 | 2005 | 85 | 0.080 |
Why?
|
| Laparoscopy | 2 | 2017 | 784 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 2418 | 0.080 |
Why?
|
| Selection, Genetic | 2 | 2014 | 537 | 0.080 |
Why?
|
| Ribonuclease T1 | 2 | 1999 | 7 | 0.080 |
Why?
|
| Arginine | 1 | 2010 | 144 | 0.080 |
Why?
|
| Endoscopy | 1 | 2014 | 374 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2009 | 39 | 0.080 |
Why?
|
| Nitrogen | 1 | 2010 | 79 | 0.080 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 303 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 1 | 2013 | 449 | 0.080 |
Why?
|
| Orthomyxoviridae | 1 | 2009 | 48 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 442 | 0.080 |
Why?
|
| NADPH Oxidases | 1 | 2009 | 85 | 0.080 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2013 | 382 | 0.080 |
Why?
|
| eIF-2 Kinase | 1 | 2009 | 50 | 0.070 |
Why?
|
| Cell Survival | 3 | 2019 | 1030 | 0.070 |
Why?
|
| Bortezomib | 1 | 2009 | 82 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2023 | 513 | 0.070 |
Why?
|
| Sensitivity and Specificity | 4 | 2007 | 2039 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2009 | 101 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 656 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2009 | 342 | 0.070 |
Why?
|
| Hot Temperature | 2 | 2002 | 217 | 0.070 |
Why?
|
| Protons | 2 | 1999 | 104 | 0.070 |
Why?
|
| Ligands | 1 | 2009 | 478 | 0.070 |
Why?
|
| Hydrogen Bonding | 3 | 2004 | 154 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2021 | 740 | 0.070 |
Why?
|
| Breast | 1 | 2009 | 297 | 0.070 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 101 | 0.070 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 2007 | 11 | 0.070 |
Why?
|
| Vulva | 1 | 2006 | 23 | 0.060 |
Why?
|
| Nucleic Acid Denaturation | 3 | 2001 | 34 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2006 | 120 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 910 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 1 | 2006 | 271 | 0.060 |
Why?
|
| Survival Rate | 3 | 2017 | 1985 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2024 | 1773 | 0.060 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 204 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2006 | 212 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2022 | 883 | 0.060 |
Why?
|
| Disease Progression | 2 | 2025 | 1562 | 0.060 |
Why?
|
| Endopeptidase K | 1 | 2005 | 13 | 0.060 |
Why?
|
| DNA Primers | 2 | 1998 | 548 | 0.060 |
Why?
|
| Time Factors | 5 | 2019 | 5580 | 0.060 |
Why?
|
| Molecular Motor Proteins | 1 | 2006 | 31 | 0.060 |
Why?
|
| Thymus Gland | 1 | 2006 | 206 | 0.060 |
Why?
|
| Dogs | 1 | 2006 | 719 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2005 | 333 | 0.060 |
Why?
|
| Scattering, Radiation | 2 | 2002 | 122 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 563 | 0.060 |
Why?
|
| X-Rays | 2 | 2002 | 139 | 0.060 |
Why?
|
| PrPC Proteins | 1 | 2005 | 13 | 0.060 |
Why?
|
| Signal Recognition Particle | 1 | 2024 | 13 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2019 | 1546 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2007 | 1158 | 0.060 |
Why?
|
| Bioreactors | 1 | 2024 | 11 | 0.060 |
Why?
|
| Emulsions | 1 | 2024 | 19 | 0.060 |
Why?
|
| Spermatozoa | 1 | 2025 | 68 | 0.060 |
Why?
|
| Maze Learning | 1 | 2024 | 32 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1230 | 0.050 |
Why?
|
| Citrus | 1 | 2024 | 4 | 0.050 |
Why?
|
| Salmonella typhimurium | 1 | 2024 | 32 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1030 | 0.050 |
Why?
|
| Proteolysis | 1 | 2025 | 124 | 0.050 |
Why?
|
| Indans | 1 | 2024 | 37 | 0.050 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2024 | 102 | 0.050 |
Why?
|
| Metal Nanoparticles | 1 | 2024 | 34 | 0.050 |
Why?
|
| Cell Hypoxia | 1 | 2025 | 187 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2019 | 1973 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2019 | 310 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2024 | 35 | 0.050 |
Why?
|
| Rifampin | 1 | 2004 | 23 | 0.050 |
Why?
|
| Sodium Chloride | 2 | 2009 | 88 | 0.050 |
Why?
|
| Phospholipase C gamma | 1 | 2023 | 14 | 0.050 |
Why?
|
| Indole Alkaloids | 1 | 2023 | 3 | 0.050 |
Why?
|
| DNA, Mitochondrial | 2 | 2015 | 197 | 0.050 |
Why?
|
| Synthetic Biology | 1 | 2023 | 16 | 0.050 |
Why?
|
| Ventral Tegmental Area | 1 | 2024 | 46 | 0.050 |
Why?
|
| Phenotype | 1 | 2010 | 2578 | 0.050 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2023 | 90 | 0.050 |
Why?
|
| Piperidines | 1 | 2024 | 171 | 0.050 |
Why?
|
| Oligoribonucleotides | 2 | 2017 | 27 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2024 | 161 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 125 | 0.050 |
Why?
|
| Adolescent | 3 | 2024 | 9895 | 0.050 |
Why?
|
| Fruit | 1 | 2023 | 81 | 0.050 |
Why?
|
| Endosonography | 1 | 2023 | 101 | 0.050 |
Why?
|
| Oceans and Seas | 1 | 2023 | 33 | 0.050 |
Why?
|
| Receptors, KIR2DL1 | 1 | 2022 | 3 | 0.050 |
Why?
|
| Organic Chemicals | 1 | 2023 | 37 | 0.050 |
Why?
|
| Fusobacterium nucleatum | 1 | 2022 | 6 | 0.050 |
Why?
|
| Histones | 1 | 2025 | 363 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 2004 | 294 | 0.050 |
Why?
|
| Fathers | 1 | 2024 | 82 | 0.050 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2023 | 32 | 0.050 |
Why?
|
| Urbanization | 1 | 2022 | 15 | 0.050 |
Why?
|
| Cochlea | 1 | 2023 | 50 | 0.050 |
Why?
|
| Drainage | 1 | 2023 | 172 | 0.050 |
Why?
|
| Replantation | 1 | 2023 | 36 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 149 | 0.050 |
Why?
|
| Rituximab | 1 | 2023 | 133 | 0.050 |
Why?
|
| Tetrahymena | 1 | 2002 | 37 | 0.050 |
Why?
|
| Cytarabine | 1 | 2023 | 225 | 0.050 |
Why?
|
| Cities | 1 | 2022 | 57 | 0.050 |
Why?
|
| Sulfites | 1 | 2022 | 33 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 930 | 0.050 |
Why?
|
| Soil | 1 | 2022 | 53 | 0.050 |
Why?
|
| Thyrotropin | 1 | 2024 | 311 | 0.050 |
Why?
|
| beta-Globins | 1 | 2022 | 3 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2025 | 2480 | 0.050 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2022 | 4 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2022 | 53 | 0.050 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2022 | 39 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 1267 | 0.050 |
Why?
|
| Manubrium | 1 | 2021 | 1 | 0.050 |
Why?
|
| Tensor Tympani | 1 | 2021 | 1 | 0.050 |
Why?
|
| Technology | 1 | 2022 | 35 | 0.050 |
Why?
|
| Triiodothyronine | 1 | 2024 | 362 | 0.050 |
Why?
|
| Malleus | 1 | 2021 | 3 | 0.050 |
Why?
|
| Oncogenes | 1 | 2022 | 100 | 0.050 |
Why?
|
| Heparin | 1 | 2023 | 186 | 0.050 |
Why?
|
| Liver | 1 | 2006 | 1238 | 0.040 |
Why?
|
| CLOCK Proteins | 1 | 2021 | 15 | 0.040 |
Why?
|
| Apolipoproteins | 1 | 2021 | 34 | 0.040 |
Why?
|
| Reward | 1 | 2024 | 209 | 0.040 |
Why?
|
| Cytidine | 1 | 2021 | 17 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2023 | 248 | 0.040 |
Why?
|
| Tendons | 1 | 2021 | 49 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2023 | 261 | 0.040 |
Why?
|
| RNA Ligase (ATP) | 1 | 2001 | 3 | 0.040 |
Why?
|
| Nucleic Acid Renaturation | 1 | 2001 | 5 | 0.040 |
Why?
|
| Speech | 1 | 2022 | 91 | 0.040 |
Why?
|
| Exonucleases | 1 | 2001 | 9 | 0.040 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2001 | 21 | 0.040 |
Why?
|
| Thyroxine | 1 | 2024 | 388 | 0.040 |
Why?
|
| Cations, Monovalent | 1 | 2001 | 7 | 0.040 |
Why?
|
| Learning | 1 | 2024 | 305 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2022 | 98 | 0.040 |
Why?
|
| Immunity | 1 | 2022 | 157 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 2001 | 39 | 0.040 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2021 | 10 | 0.040 |
Why?
|
| Avidin | 1 | 2001 | 5 | 0.040 |
Why?
|
| Hearing | 1 | 2021 | 64 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 166 | 0.040 |
Why?
|
| Muscles | 1 | 2021 | 193 | 0.040 |
Why?
|
| Genes, Bacterial | 2 | 2012 | 199 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 367 | 0.040 |
Why?
|
| Scattering, Small Angle | 1 | 2021 | 37 | 0.040 |
Why?
|
| Chromatography, Gel | 1 | 2001 | 104 | 0.040 |
Why?
|
| Motivation | 1 | 2024 | 310 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2024 | 244 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 459 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 179 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 996 | 0.040 |
Why?
|
| Biotin | 1 | 2001 | 46 | 0.040 |
Why?
|
| Mastoid | 1 | 2021 | 16 | 0.040 |
Why?
|
| Ear Canal | 1 | 2021 | 17 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2023 | 294 | 0.040 |
Why?
|
| Stents | 1 | 2023 | 422 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2021 | 73 | 0.040 |
Why?
|
| Animal Distribution | 1 | 2021 | 30 | 0.040 |
Why?
|
| Cattle | 1 | 2001 | 386 | 0.040 |
Why?
|
| Organoids | 1 | 2021 | 78 | 0.040 |
Why?
|
| Threonine | 1 | 2020 | 34 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 156 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2025 | 454 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 164 | 0.040 |
Why?
|
| Titrimetry | 1 | 1999 | 15 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 1349 | 0.040 |
Why?
|
| Reoperation | 1 | 2023 | 707 | 0.040 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2019 | 1 | 0.040 |
Why?
|
| Virion | 1 | 2020 | 62 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 15 | 0.040 |
Why?
|
| Bacteriophage T7 | 1 | 1999 | 7 | 0.040 |
Why?
|
| Isocitrates | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hydroxides | 1 | 1999 | 9 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2019 | 15 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 123 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2019 | 62 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 463 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 1429 | 0.040 |
Why?
|
| Vertebrates | 1 | 2020 | 113 | 0.040 |
Why?
|
| Vestibular Aqueduct | 1 | 2019 | 1 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 164 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2019 | 104 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 180 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 300 | 0.040 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2019 | 41 | 0.040 |
Why?
|
| MERRF Syndrome | 1 | 2018 | 2 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 1998 | 18 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2021 | 489 | 0.040 |
Why?
|
| Tumor Hypoxia | 1 | 2019 | 43 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 7229 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2013 | 935 | 0.040 |
Why?
|
| Myoblasts | 1 | 2018 | 33 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 412 | 0.040 |
Why?
|
| Axons | 1 | 2019 | 189 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 52 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 667 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2023 | 4671 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 1876 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2017 | 1316 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2023 | 1805 | 0.030 |
Why?
|
| Magnesium Chloride | 1 | 1997 | 6 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1997 | 43 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2021 | 447 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 553 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 454 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2012 | 564 | 0.030 |
Why?
|
| Laparotomy | 1 | 2017 | 69 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 1997 | 109 | 0.030 |
Why?
|
| RNA, Transfer, Arg | 1 | 2017 | 2 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1998 | 253 | 0.030 |
Why?
|
| Endogenous Retroviruses | 1 | 2017 | 10 | 0.030 |
Why?
|
| Esters | 1 | 1997 | 31 | 0.030 |
Why?
|
| Protein Splicing | 1 | 2017 | 2 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2017 | 67 | 0.030 |
Why?
|
| Stem Cells | 1 | 2020 | 394 | 0.030 |
Why?
|
| Risk Factors | 2 | 2022 | 5961 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 100 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 3240 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 299 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 1215 | 0.030 |
Why?
|
| Carbon | 1 | 1997 | 97 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 488 | 0.030 |
Why?
|
| Butadienes | 1 | 2016 | 34 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 296 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 342 | 0.030 |
Why?
|
| GC Rich Sequence | 1 | 2016 | 9 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2020 | 504 | 0.030 |
Why?
|
| Eubacterium | 1 | 1995 | 2 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2015 | 12 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 594 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 385 | 0.030 |
Why?
|
| Models, Structural | 1 | 1995 | 58 | 0.030 |
Why?
|
| NADH Dehydrogenase | 1 | 2015 | 23 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 58 | 0.030 |
Why?
|
| Nitriles | 1 | 2016 | 157 | 0.030 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2015 | 36 | 0.030 |
Why?
|
| Cycloheximide | 1 | 2015 | 58 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 287 | 0.030 |
Why?
|
| Protein Aggregates | 1 | 2015 | 28 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 2015 | 99 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 483 | 0.030 |
Why?
|
| Patient Selection | 1 | 2019 | 709 | 0.030 |
Why?
|
| Thiourea | 1 | 2014 | 10 | 0.030 |
Why?
|
| Potassium Chloride | 1 | 1995 | 88 | 0.030 |
Why?
|
| Point Mutation | 1 | 1995 | 247 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 49 | 0.030 |
Why?
|
| Polyesters | 1 | 2014 | 44 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 82 | 0.030 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 2014 | 21 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2014 | 49 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2014 | 75 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 164 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2013 | 40 | 0.030 |
Why?
|
| RNA 3' End Processing | 1 | 2013 | 1 | 0.030 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2013 | 12 | 0.030 |
Why?
|
| Amino Acid Transport Systems | 1 | 2013 | 4 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1619 | 0.030 |
Why?
|
| Glucose | 1 | 2016 | 701 | 0.030 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2013 | 20 | 0.020 |
Why?
|
| Organelles | 1 | 2013 | 58 | 0.020 |
Why?
|
| Auditory Threshold | 1 | 2013 | 16 | 0.020 |
Why?
|
| Hypertonic Solutions | 1 | 2012 | 17 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 356 | 0.020 |
Why?
|
| Glutamate-tRNA Ligase | 1 | 2012 | 1 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2012 | 109 | 0.020 |
Why?
|
| Virus Integration | 1 | 2012 | 17 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2012 | 46 | 0.020 |
Why?
|
| Hybridomas | 1 | 2012 | 75 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 145 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 376 | 0.020 |
Why?
|
| COS Cells | 1 | 2012 | 168 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 179 | 0.020 |
Why?
|
| Nanostructures | 1 | 2013 | 89 | 0.020 |
Why?
|
| Archaea | 1 | 2012 | 22 | 0.020 |
Why?
|
| Eukaryota | 1 | 2012 | 47 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 145 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 284 | 0.020 |
Why?
|
| Pneumothorax | 1 | 2012 | 52 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2017 | 2614 | 0.020 |
Why?
|
| AlkB Homolog 8, tRNA Methyltransferase | 1 | 2010 | 2 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2010 | 19 | 0.020 |
Why?
|
| Environment | 1 | 2012 | 231 | 0.020 |
Why?
|
| Bacillus | 1 | 2010 | 12 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2014 | 777 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2012 | 348 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2010 | 111 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 713 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 3927 | 0.020 |
Why?
|
| HIV Infections | 1 | 2020 | 974 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 416 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 17 | 0.020 |
Why?
|
| RNA, Transfer, Asn | 1 | 2009 | 1 | 0.020 |
Why?
|
| RNA, Transfer, Ile | 1 | 2009 | 1 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 27 | 0.020 |
Why?
|
| Static Electricity | 1 | 2010 | 97 | 0.020 |
Why?
|
| DNA Probes | 1 | 2009 | 77 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2014 | 634 | 0.020 |
Why?
|
| Virus Assembly | 1 | 2009 | 22 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 87 | 0.020 |
Why?
|
| Leucine | 1 | 2009 | 62 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 2009 | 31 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 280 | 0.020 |
Why?
|
| DNA Repair | 1 | 2010 | 376 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1645 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 2086 | 0.020 |
Why?
|
| DNA Ligases | 1 | 2007 | 13 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2007 | 63 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2007 | 217 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2007 | 692 | 0.020 |
Why?
|
| Drug Resistance, Multiple | 1 | 2005 | 20 | 0.010 |
Why?
|
| Neurons | 1 | 2014 | 1653 | 0.010 |
Why?
|
| Escherichia coli K12 | 1 | 2005 | 4 | 0.010 |
Why?
|
| Spliceosomes | 1 | 2005 | 49 | 0.010 |
Why?
|
| Ribonucleotides | 1 | 2004 | 13 | 0.010 |
Why?
|
| Intestine, Large | 1 | 2004 | 15 | 0.010 |
Why?
|
| Rosaniline Dyes | 1 | 2004 | 9 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 89 | 0.010 |
Why?
|
| Energy Transfer | 1 | 2004 | 26 | 0.010 |
Why?
|
| Fluorescence | 1 | 2004 | 106 | 0.010 |
Why?
|
| Esophagus | 1 | 2004 | 111 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 516 | 0.010 |
Why?
|
| Stomach | 1 | 2004 | 115 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2004 | 358 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2004 | 310 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 594 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 819 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2001 | 41 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2591 | 0.010 |
Why?
|
| Solutions | 1 | 2000 | 86 | 0.010 |
Why?
|
| Synchrotrons | 1 | 2000 | 33 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 1881 | 0.010 |
Why?
|
| RNA, Protozoan | 1 | 1999 | 5 | 0.010 |
Why?
|